Key Metrics
CiteScore 

3
Eigenfactor 

0.001 - 0.005
Impact Factor 

< 5
SJR 

Q3Pharmacology

Recommended pre-submission checks
Powered by 

Topics Covered on Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine Journal Specifications
Indexed in the following public directories
Scopus
DOAJ
SJR
| Overview | |
| Publisher | Dove Medical Press |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Pharmacogenomics and Personalized Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmacogenomics and Personalized Medicine
Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
- 2 Apr 2026
- Pharmacogenomics and Personalized Medicine
NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
- 10 Mar 2026
- Pharmacogenomics and Personalized Medicine
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
- 2 Apr 2026
- Pharmacogenomics and Personalized Medicine
NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
- 10 Mar 2026
- Pharmacogenomics and Personalized Medicine
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma.
- 1 Jan 2026
- Pharmacogenomics and personalized medicine